IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) PB Ratio: 30.01

Is IDEXX Laboratories, Inc.’s P/B ratio high or low?

IDEXX Laboratories, Inc.'s P/B ratio of 30.01 is 34% below its 5-year average of 45.24, near the low end of its 5-year range (18.68–90.93).

The P/B ratio for IDEXX Laboratories, Inc. (IDXX) is 30.01. It is below its 12-month average by 8.92% (32.95).

IDXX PB Ratio Chart

IDXX PB Ratio
30.01+2.28% 1Y
Zoom

IDXX Average PB Ratio Chart

IDXX Current vs Average PB Ratio Chart

IDXX PB Ratio Metrics

PB RATIO

30.01

PB RATIO AVG TTM

32.95

PB RATIO AVG 3Y

30.73

PB RATIO AVG 5Y

45.24

PB RATIO AVG 10Y

179.63

PB RATIO AVG 15Y

174.74

PB RATIO AVG 20Y

132.79

CURRENT VS TTM AVG

-8.92%

CURRENT VS 3Y AVG

-2.35%

CURRENT VS 5Y AVG

-33.67%

CURRENT VS 10Y AVG

-83.29%

CURRENT VS 15Y AVG

-82.83%

CURRENT VS 20Y AVG

-77.40%

IDXX Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)30.0132.9530.7345.24
Humana Inc. (HUM)$43.60B2.361.632.302.91
Agilent Technologies, Inc. (A)$38.26B5.405.576.126.99
Zoetis Inc. (ZTS)$34.46B10.7413.0015.2316.75
Centene Corporation (CNC)$32.69B1.530.871.211.41
IQVIA Holdings Inc. (IQV)$31.09B5.085.405.996.64
DexCom, Inc. (DXCM)$30.17B10.4110.9316.3118.94
Biogen Inc. (BIIB)$29.39B1.581.341.772.40
Regeneron Pharmaceuticals, Inc. (REGN)$63.48B2.112.353.223.55
Veeva Systems Inc. (VEEV)$27.37B3.815.866.769.03

P/B vs. its own history

At 30.01, P/B is in its normal range — richer than 50% of its 20-year range.

20-year low

2.02

median

30.21

20-year high

1303.45

cheaperricher

Book Value Analysis

P/B Ratio

30.01

Market Price / Book Value per Share

IDEXX Laboratories, Inc. PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. PB Ratio FAQ

What is the P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The P/B ratio for IDXX stock is 30.01.
Is IDEXX Laboratories, Inc.'s P/B ratio high or low?
IDEXX Laboratories, Inc.'s P/B ratio of 30.01 is 34% below its 5-year average of 45.24, near the low end of its 5-year range (18.68–90.93).
What is the TTM average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The TTM average P/B ratio for IDXX stock is 32.95.
What is the 3Y average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average P/B ratio for IDXX stock is 30.73.
What is the 5Y average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average P/B ratio for IDXX stock is 45.24.
What is the 10Y average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average P/B ratio for IDXX stock is 179.63.
What is the 15Y average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average P/B ratio for IDXX stock is 174.74.
What is the 20Y average P/B ratio for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average P/B ratio for IDXX stock is 132.79.

IDEXX Laboratories, Inc. PB Ratio History

DATEPB RATIO
2026-06-0930.01
2026-06-0829.09
2026-06-0529.14
2026-06-0429.28
2026-06-0329.07
2026-06-0228.56
2026-06-0129.38
2026-05-2929.22
2026-05-2829.45
2026-05-2728.57
2026-05-2628.89
2026-05-2229.00
2026-05-2128.67
2026-05-2028.70
2026-05-1928.33
2026-05-1828.30
2026-05-1527.41
2026-05-1427.63
2026-05-1327.41
2026-05-1227.68
2026-05-1127.58
2026-05-0829.04
2026-05-0729.67
2026-05-0630.03
2026-05-0529.19
2026-05-0428.30
2026-05-0128.52
2026-04-3028.18
2026-04-2927.82
2026-04-2828.56
2026-04-2728.89
2026-04-2428.44
2026-04-2328.19
2026-04-2229.06
2026-04-2128.59
2026-04-2029.30
2026-04-1729.61
2026-04-1628.64
2026-04-1529.18
2026-04-1429.35
2026-04-1328.85
2026-04-1028.29
2026-04-0929.39
2026-04-0829.74
2026-04-0728.89
2026-04-0629.02
2026-04-0228.62
2026-04-0128.38
2026-03-3128.24
2026-03-3028.00
2026-03-2728.06
2026-03-2628.81
2026-03-2528.93
2026-03-2428.65
2026-03-2329.07
2026-03-2029.01
2026-03-1929.14
2026-03-1829.00
2026-03-1729.50
2026-03-1629.47
2026-03-1328.84
2026-03-1228.70
2026-03-1130.18
2026-03-1030.09
2026-03-0930.68
2026-03-0630.57
2026-03-0531.10
2026-03-0432.60
2026-03-0331.94
2026-03-0232.00
2026-02-2733.00
2026-02-2633.20
2026-02-2533.04
2026-02-2432.63
2026-02-2331.31
2026-02-2031.94
2026-02-1932.59
2026-02-1832.81
2026-02-1732.36
2026-02-1332.52
2026-02-1231.89
2026-02-1133.52
2026-02-1033.41
2026-02-0933.06
2026-02-0633.31
2026-02-0533.26
2026-02-0433.22
2026-02-0332.69
2026-02-0233.05
2026-01-3034.65
2026-01-2934.97
2026-01-2835.54
2026-01-2735.90
2026-01-2636.06
2026-01-2335.86
2026-01-2235.71
2026-01-2135.99
2026-01-2035.45
2026-01-1636.97
2026-01-1536.80
2026-01-1436.71
2026-01-1336.90
2026-01-1237.45
2026-01-0936.86
2026-01-0836.81
2026-01-0736.92
2026-01-0636.53
2026-01-0535.25
2026-01-0234.62
2025-12-3134.96
2025-12-3035.26
2025-12-2935.55
2025-12-2635.58
2025-12-2435.56
2025-12-2335.26
2025-12-2236.28
2025-12-1936.19
2025-12-1836.02
2025-12-1735.95
2025-12-1635.82
2025-12-1536.20
2025-12-1236.39
2025-12-1136.56
2025-12-1036.27
2025-12-0936.12
2025-12-0836.52
2025-12-0536.90
2025-12-0437.08
2025-12-0337.51
2025-12-0237.86
2025-12-0137.67
2025-11-2838.91
2025-11-2639.06
2025-11-2539.62
2025-11-2438.87
2025-11-2137.51
2025-11-2035.62
2025-11-1936.02
2025-11-1834.63
2025-11-1734.57
2025-11-1435.65
2025-11-1336.25
2025-11-1236.87
2025-11-1136.82
2025-11-1036.67
2025-11-0736.61
2025-11-0636.88
2025-11-0537.22
2025-11-0437.32
2025-11-0337.36
2025-10-3134.95
2025-10-3034.90
2025-10-2934.85
2025-10-2835.22
2025-10-2735.94
2025-10-2435.58
2025-10-2335.46
2025-10-2235.19
2025-10-2135.37
2025-10-2035.72
2025-10-1735.28
2025-10-1635.39
2025-10-1535.49
2025-10-1435.36
2025-10-1335.16
2025-10-1034.21
2025-10-0934.91
2025-10-0834.97
2025-10-0734.83
2025-10-0634.85
2025-10-0335.04
2025-10-0235.19
2025-10-0134.43
2025-09-3035.47
2025-09-2935.01
2025-09-2635.10
2025-09-2534.32
2025-09-2434.82
2025-09-2336.00
2025-09-2235.76
2025-09-1936.43
2025-09-1836.39
2025-09-1735.58
2025-09-1635.85
2025-09-1535.75
2025-09-1235.60
2025-09-1135.82
2025-09-1035.42
2025-09-0936.40
2025-09-0836.25
2025-09-0535.70
2025-09-0435.56
2025-09-0335.20
2025-09-0235.50
2025-08-2935.93
2025-08-2835.92
2025-08-2735.58
2025-08-2635.63
2025-08-2535.61
2025-08-2235.84
2025-08-2135.15
2025-08-2035.52
2025-08-1935.35
2025-08-1835.41
2025-08-1536.13
2025-08-1436.31
2025-08-1336.86
2025-08-1236.21
2025-08-1136.21
2025-08-0836.54
2025-08-0736.09
2025-08-0634.65
2025-08-0535.64
2025-08-0437.91
2025-08-0130.30
2025-07-3130.23
2025-07-3032.37
2025-07-2932.42
2025-07-2832.05
2025-07-2531.98
2025-07-2431.11
2025-07-2330.59
2025-07-2230.10
2025-07-2129.47
2025-07-1829.11
2025-07-1729.35
2025-07-1629.45
2025-07-1529.80
2025-07-1430.07
2025-07-1130.18
2025-07-1030.61
2025-07-0930.59
2025-07-0830.49
2025-07-0730.87
2025-07-0330.95
2025-07-0230.70
2025-07-0130.70
2025-06-3030.34
2025-06-2730.06
2025-06-2629.86
2025-06-2530.01
2025-06-2430.01
2025-06-2329.68
2025-06-2029.64
2025-06-1829.41
2025-06-1729.45
2025-06-1629.92
2025-06-1329.57
2025-06-1229.81
2025-06-1129.66
2025-06-1029.75
2025-06-0929.34
2025-06-0629.70
2025-06-0529.54
2025-06-0429.69
2025-06-0329.75
2025-06-0229.13
2025-05-3029.04
2025-05-2929.17
2025-05-2829.10

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky